Bay Street Likely To See Muted Start

Canadian shares are likely to open on a muted note Tuesday morning, as investors await some crucial economic data from the U.S., and comments from several Fed officials for clues about the interest rate trajectory. Movements are likely to remain somewhat rangebound in lackluster trade. The Canadian market ended weak on Monday, losing for a...

Read More

Intra-Cellular Says Phase3 Trial Study 502 Of Lumateperone In MDD Meets Primary Endpoint

Biopharmaceutical company Intra-Cellular Therapies, Inc. (ITCI) announced Tuesday positive topline results from Study 502 evaluating lumateperone 42 mg as an adjunctive therapy to antidepressants for the treatment of Major Depressive Disorder (MDD). This trial, in conjunction with the previously reported positive Phase 3 study, Study 501, forms the basis for lumateperone sNDA for the adjunctive...

Read More